Vincera's weight loss program uses GLP-1 receptor agonists (semaglutide and tirzepatide) paired with monthly clinical oversight, regular lab monitoring, and lifestyle support. Built for patients who want medically supervised, sustained results.
GLP-1 also acts on the pancreas and liver to improve metabolic health.
GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed for type 2 diabetes management and are now widely prescribed for weight management. They work by slowing gastric emptying, reducing appetite signals in the brain, and improving insulin sensitivity. Your provider will discuss what results are realistic for your situation. Individual results vary.
A good fit: Adults who have struggled to achieve sustained weight loss through lifestyle changes alone, who are looking for a medically supervised, evidence-based approach, and who are prepared to commit to monthly clinical follow-up.
Not the right fit: Patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, active pancreatitis, or pregnancy. Before prescribing, your physician will review your full medical history.
Need to learn more? Schedule a free 15-minute consult with a care coordinator. No card required.
Already know this is what you want? Skip the consult and enroll directly through pricing.